Mealey's (July 11, 2018, 8:26 AM EDT) -- WILMINGTON, Del. — Two excess insurers have asked the Delaware Superior Court to dismiss with prejudice or stay Pfizer Inc.’s lawsuit seeking coverage for underlying class action claims that its directors and officers made misrepresentations and omissions as to the safety of two COX-2 inhibitor drugs, arguing that their related federal lawsuit is the more appropriate forum (Pfizer Inc. v. Arch Specialty Insurance Company and U.S. Specialty Insurance Company, N18C-01-310, Del. Super.)....